The Trump administration is redoubling its efforts to phase out animal testing in drug development and seeking to develop new ...
Morning Overview on MSN
FDA urges alternatives to animal testing in early-stage drug development
The U.S. Food and Drug Administration is actively steering drug developers away from traditional animal studies and toward human-biology-based testing methods for monoclonal antibody programs. The ...
Health authorities in the U.S. are continuing their move away from animal testing in drug development, with the FDA signaling an openness to new approaches that haven’t been validated and the National ...
March 18 (Reuters) - The U.S. Food and Drug Administration on Wednesday issued a draft guidance to help companies reduce ...
New draft guidance from the FDA is urging pharma companies to accelerate efforts to transition from animal testing to ...
MedPage Today on MSN
FDA Proposes More Flexibility in Alternatives to Animal Testing in Drug Development
Non-animal testing methods could save drugmakers time and money, officials say ...
The FDA has released a draft guidance outlining how drug developers can validate new approach methodologies (NAMs) as alternatives to animal testing in preclinical drug developmen ...
In April 2025, the FDA announced plans to shift biomedical research for monoclonal antibodies and other medications away from animal testing toward new approaches. One year later, much speculation ...
Around 348 B.C., Aristotle took a two-year trip to the eastern Aegean island of Lesbos to study animals in a lagoon. Along with observing the creatures in their natural habitat and surmising, among ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results